Breaking the $62 Billion Global Infection Crisis with DiviDiaper
Preventable infections and complications related to diapers and incontinence cost the world over $62 billion every year. DiviDiaper's revolutionary designs break the infection chain.
The Global Problem
Infant Impact
A significant percentage of infants experience diaper rash or incontinence-associated dermatitis (IAD), causing discomfort and potential complications.
Adult Impact
Many adults in care settings experience diaper rash or IAD, contributing to decreased quality of life and increased healthcare complexity.
$62 Billion Annual Cost
Global cost of preventable infections related to diapers and incontinence continues to strain healthcare systems worldwide.
Hospital-acquired infections (HAIs)—including sepsis, urinary tract infections (UTIs), and skin breakdown—are a massive burden on families, hospitals, and health systems worldwide[WHO][Sepsis Alliance].
Diaper Dermatitis & Incontinence-Associated Dermatitis
What is it:
Painful, inflamed skin caused by prolonged exposure to moisture, urine, and stool.
How common:
Up to 75% of infants and 25% of adults in care settings experience diaper rash or IAD.
Why it happens:
Urine and stool mixing raises skin pH, activates enzymes, and damages the skin barrier. Fungal (Candida) and bacterial infections can develop in as many as 92% of severe cases[Medscape].
Catheter-Associated Urinary Tract Infection (CAUTI)
-
A catheter-associated urinary tract infection (CAUTI) occurs when germs (usually bacteria) enter the urinary tract via a urinary catheter, causing infection. CAUTIs are among the most common healthcare-associated infections (HAIs), accounting for up to 75% of hospital-acquired UTIs. About 15–25% of hospitalized patients receive urinary catheters, and prolonged catheter use is the single greatest risk factor for CAUTI
-
How common:
75% of hospital UTIs are catheter-associated[CDC].
-
Why it happens:
Catheters exposed to stool and bacteria dramatically increase infection risk.
-
How DiviDiaper helps:
Cathease™ isolates the catheter from stool and skin, reducing CAUTI risk by up to 75%[PMC11704929].
